Seelos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | Buy€92,069 | Raj Mehra | Individual | 9,469.63 | €9.72 | |
30 Nov 23 | Buy€91,894 | Michael Golembiewski | Individual | 10,375 | €8.86 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 34,237 | 1.2% |
Institutions | 339,481 | 11.9% |
General Public | 2,486,049 | 86.9% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 463.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
58,332 | €29.9k | 104% | 0.01% | |||
57,836 | €29.6k | 155% | 0.01% | |||
53,620 | €27.5k | 284% | no data | |||
47,404 | €24.3k | 43.2% | no data | |||
35,108 | €18.0k | -1.06% | no data | |||
23,143 | €11.8k | 0% | no data | |||
19,702 | €10.1k | 126% | no data | |||
15,758 | €8.1k | 79.7% | no data | |||
12,801 | €6.6k | 249% | no data | |||
11,040 | €5.7k | -81% | 0.03% | |||
10,859 | €5.6k | 0% | no data | |||
6,995 | €3.6k | 0% | no data | |||
3,751 | €1.9k | 0% | no data | |||
2,876 | €1.5k | 0% | no data | |||
2,008 | €1.0k | 0% | no data | |||
1,635 | €837.1 | -48.2% | no data | |||
1,618 | €828.4 | 0% | no data | |||
1,486 | €760.8 | 0% | no data | |||
1,314 | €672.8 | 99.1% | no data | |||
1,270 | €650.2 | 2,440% | no data | |||
1,252 | €641.0 | 0% | no data | |||
1,023 | €523.7 | -4.57% | no data | |||
1,000 | €512.0 | 60% | no data | |||
504 | €258.0 | 101% | no data | |||
469 | €240.1 | 0% | no data |